Fludeoxyglucose F-18 Injection
Product Images NDC 24450-647
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F-18 (NDC 24450-647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Brigham And Women`s Hospital, Inc., The, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Drug Product Label (Fdglabel)
This is a description of a multiple-dose vial of Fludeoxyglucose F-18 injection, a diagnostic radiopharmaceutical used for intravenous use only. The manufacturer is Brigham & Women's Hospital, and the lot number is 18FFDG1205244. The calibration is 4890.00 mCi at 0 velocity, and the concentration is between 20 and 300 mCi/mL. The expiration time is 12 hours after the end of synthesis. There is also a warning that the dispensing of this product is prohibited without a prescription due to U.S. law.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.